Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · IOC 2027

Uveitis And Ocular Inflammatory Diseases at IOC 2027

Part of the IOC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Uveitis And Ocular Inflammatory Diseases Session

Uveitis and ocular inflammatory diseases encompass a range of conditions marked by inflammation affecting the uveal tract—comprising the iris, ciliary body, and choroid. This inflammation may stem from infections, autoimmune disorders, or unknown origins. Symptoms include eye pain, redness, light sensitivity, blurred vision, and occasionally floaters. Timely diagnosis and treatment are critical to prevent complications like glaucoma, cataracts, and permanent vision loss.

Treatment typically involves corticosteroids—applied topically or administered systemically—to reduce inflammation, often complemented by targeted therapies addressing underlying causes when identified. Collaboration between ophthalmologists, rheumatologists, or infectious disease specialists is common for comprehensive patient care. Continuous monitoring is essential due to the potential for recurrence. Advances in diagnostic imaging and treatment methods are enhancing outcomes, underscoring the importance of early intervention and personalized treatment plans.

Topics Covered in Uveitis And Ocular Inflammatory Diseases

Topic 01

Anterior & Intermediate Uveitis

Topic 02

Posterior Uveitis & Panuveitis

Topic 03

HLA-B27 Uveitis

Topic 04

Scleritis & Episcleritis

Topic 05

Biologic Immunomodulators

Topic 06

Uveitic Glaucoma & Cataract

Related Scientific Sessions at IOC 2027

Why Attend the Uveitis And Ocular Inflammatory Diseases Conference 2027

Earn CPD Credit

Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.

Present Your Research

Oral and poster slots for original Uveitis And Ocular Inflammatory Diseases work, reviewed by the scientific committee.

Network Globally

Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.

Publish & Get Indexed

Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.

Learn from Keynotes

Plenary lectures from leading voices shaping Uveitis And Ocular Inflammatory Diseases research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join IOC 2027 for the Uveitis And Ocular Inflammatory Diseases track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Uveitis And Ocular Inflammatory Diseases Conference 2027 — FAQs

What is the Uveitis And Ocular Inflammatory Diseases track at IOC 2027?

The Uveitis And Ocular Inflammatory Diseases track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Uveitis And Ocular Inflammatory Diseases. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Uveitis And Ocular Inflammatory Diseases sessions?

Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Uveitis And Ocular Inflammatory Diseases are all welcome — whether presenting or attending.

Can I present my research in the Uveitis And Ocular Inflammatory Diseases track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Uveitis And Ocular Inflammatory Diseases sessions?

Yes. IOC 2027 is a hybrid conference — attend the Uveitis And Ocular Inflammatory Diseases track in person in Singapore or join live online, with on-demand access afterward.

Join the IOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us